 Scott Demarest
Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spasms, Infantile | 30 | 2024 | 103 | 10.390 |
Why?
| | Epileptic Syndromes | 25 | 2024 | 66 | 8.550 |
Why?
| | Epilepsy | 19 | 2023 | 277 | 5.750 |
Why?
| | Precision Medicine | 5 | 2022 | 338 | 1.890 |
Why?
| | Vision Disorders | 6 | 2023 | 130 | 1.590 |
Why?
| | Anticonvulsants | 9 | 2023 | 178 | 1.580 |
Why?
| | Genetic Testing | 5 | 2023 | 379 | 1.530 |
Why?
| | Seizures | 13 | 2023 | 339 | 1.400 |
Why?
| | Gene Editing | 2 | 2021 | 57 | 1.360 |
Why?
| | Pregnanolone | 2 | 2023 | 20 | 1.100 |
Why?
| | Epilepsies, Myoclonic | 3 | 2020 | 41 | 0.930 |
Why?
| | Epilepsy, Tonic-Clonic | 1 | 2023 | 3 | 0.910 |
Why?
| | Genetic Therapy | 2 | 2021 | 257 | 0.860 |
Why?
| | Disorders of Excessive Somnolence | 1 | 2022 | 25 | 0.800 |
Why?
| | Long QT Syndrome | 1 | 2022 | 59 | 0.780 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 30 | 0.770 |
Why?
| | Haploinsufficiency | 1 | 2021 | 42 | 0.770 |
Why?
| | Child | 26 | 2024 | 18352 | 0.740 |
Why?
| | Neurodevelopmental Disorders | 2 | 2021 | 109 | 0.730 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2022 | 117 | 0.710 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2023 | 242 | 0.710 |
Why?
| | Child, Preschool | 16 | 2024 | 9079 | 0.700 |
Why?
| | Infant | 17 | 2024 | 7935 | 0.680 |
Why?
| | Sleep Wake Disorders | 1 | 2022 | 232 | 0.640 |
Why?
| | Brain Waves | 1 | 2018 | 21 | 0.620 |
Why?
| | Electroencephalography | 9 | 2023 | 362 | 0.620 |
Why?
| | Symptom Assessment | 1 | 2019 | 118 | 0.600 |
Why?
| | Developmental Disabilities | 2 | 2019 | 239 | 0.570 |
Why?
| | Humans | 48 | 2024 | 114716 | 0.560 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2018 | 440 | 0.510 |
Why?
| | Genetic Predisposition to Disease | 1 | 2023 | 2099 | 0.480 |
Why?
| | MELAS Syndrome | 1 | 2014 | 4 | 0.480 |
Why?
| | Genetic Association Studies | 3 | 2020 | 344 | 0.440 |
Why?
| | Quality of Life | 6 | 2023 | 2357 | 0.430 |
Why?
| | DNA, Mitochondrial | 1 | 2014 | 182 | 0.430 |
Why?
| | Movement Disorders | 3 | 2023 | 46 | 0.410 |
Why?
| | Adolescent | 12 | 2024 | 17808 | 0.410 |
Why?
| | Clinical Trials as Topic | 3 | 2021 | 934 | 0.400 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2538 | 0.380 |
Why?
| | Adrenocorticotropic Hormone | 3 | 2023 | 129 | 0.380 |
Why?
| | Double-Blind Method | 3 | 2023 | 1662 | 0.360 |
Why?
| | Cohort Studies | 5 | 2021 | 4899 | 0.350 |
Why?
| | Lennox Gastaut Syndrome | 2 | 2021 | 16 | 0.340 |
Why?
| | Male | 20 | 2023 | 55558 | 0.330 |
Why?
| | Surveys and Questionnaires | 6 | 2023 | 4622 | 0.330 |
Why?
| | Rett Syndrome | 3 | 2024 | 23 | 0.320 |
Why?
| | Female | 20 | 2023 | 59486 | 0.310 |
Why?
| | Psychometrics | 4 | 2024 | 607 | 0.290 |
Why?
| | Mutation | 5 | 2021 | 3349 | 0.290 |
Why?
| | Treatment Outcome | 6 | 2023 | 9089 | 0.280 |
Why?
| | Brain | 2 | 2014 | 2369 | 0.260 |
Why?
| | Phenotype | 5 | 2021 | 2811 | 0.250 |
Why?
| | Young Adult | 6 | 2024 | 10462 | 0.240 |
Why?
| | Adult | 9 | 2024 | 30543 | 0.230 |
Why?
| | Status Epilepticus | 1 | 2023 | 32 | 0.220 |
Why?
| | Sex Factors | 2 | 2019 | 1717 | 0.220 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2023 | 111 | 0.210 |
Why?
| | Checklist | 1 | 2023 | 83 | 0.200 |
Why?
| | Brain Diseases | 1 | 2023 | 124 | 0.200 |
Why?
| | Vigabatrin | 2 | 2023 | 18 | 0.200 |
Why?
| | Vagus Nerve Stimulation | 2 | 2019 | 21 | 0.190 |
Why?
| | Neurologists | 1 | 2021 | 18 | 0.190 |
Why?
| | Oligonucleotides, Antisense | 1 | 2021 | 100 | 0.190 |
Why?
| | Intellectual Disability | 1 | 2022 | 129 | 0.180 |
Why?
| | Infusions, Intraventricular | 1 | 2020 | 4 | 0.180 |
Why?
| | Neuronal Ceroid-Lipofuscinoses | 1 | 2020 | 3 | 0.180 |
Why?
| | Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2020 | 4 | 0.180 |
Why?
| | Aminopeptidases | 1 | 2020 | 9 | 0.180 |
Why?
| | Serine Proteases | 1 | 2020 | 14 | 0.180 |
Why?
| | Infusion Pumps | 1 | 2020 | 31 | 0.180 |
Why?
| | Leukoencephalopathies | 1 | 2020 | 21 | 0.180 |
Why?
| | Drug Therapy, Combination | 1 | 2023 | 954 | 0.170 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 4406 | 0.170 |
Why?
| | Hemiplegia | 1 | 2019 | 18 | 0.170 |
Why?
| | Electrocardiography | 1 | 2022 | 562 | 0.170 |
Why?
| | Dystonic Disorders | 1 | 2019 | 16 | 0.170 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 43 | 0.170 |
Why?
| | DNA Polymerase gamma | 1 | 2019 | 7 | 0.160 |
Why?
| | Speech Disorders | 1 | 2019 | 30 | 0.160 |
Why?
| | Autonomic Nervous System Diseases | 1 | 2019 | 27 | 0.160 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 1 | 2019 | 15 | 0.160 |
Why?
| | Spasm | 3 | 2023 | 19 | 0.160 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 2019 | 24 | 0.160 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2019 | 35 | 0.160 |
Why?
| | Age of Onset | 2 | 2017 | 447 | 0.160 |
Why?
| | Neurosurgical Procedures | 1 | 2020 | 152 | 0.160 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 42 | 0.160 |
Why?
| | Reproducibility of Results | 5 | 2024 | 2762 | 0.160 |
Why?
| | Pilot Projects | 1 | 2023 | 1370 | 0.150 |
Why?
| | Delphi Technique | 1 | 2019 | 160 | 0.150 |
Why?
| | Retrospective Studies | 5 | 2023 | 12513 | 0.150 |
Why?
| | Receptors, GABA-A | 1 | 2019 | 82 | 0.150 |
Why?
| | Family | 1 | 2022 | 590 | 0.150 |
Why?
| | Preexisting Condition Coverage | 1 | 2017 | 2 | 0.150 |
Why?
| | Cognition Disorders | 2 | 2019 | 476 | 0.150 |
Why?
| | Family Health | 1 | 2019 | 194 | 0.150 |
Why?
| | Drug Resistant Epilepsy | 1 | 2018 | 45 | 0.150 |
Why?
| | Communication | 1 | 2023 | 747 | 0.150 |
Why?
| | Prednisolone | 1 | 2017 | 75 | 0.150 |
Why?
| | Calcium-Binding Proteins | 1 | 2019 | 207 | 0.140 |
Why?
| | Infant, Newborn | 3 | 2022 | 5035 | 0.140 |
Why?
| | Sequence Analysis, DNA | 1 | 2020 | 728 | 0.140 |
Why?
| | Caregivers | 1 | 2023 | 714 | 0.140 |
Why?
| | Genomics | 1 | 2021 | 639 | 0.140 |
Why?
| | Recombinant Proteins | 1 | 2020 | 1233 | 0.140 |
Why?
| | Health Surveys | 1 | 2018 | 443 | 0.130 |
Why?
| | Patient Care Team | 1 | 2020 | 517 | 0.130 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 529 | 0.120 |
Why?
| | Follow-Up Studies | 1 | 2023 | 4420 | 0.120 |
Why?
| | Autoimmune Diseases of the Nervous System | 1 | 2014 | 21 | 0.120 |
Why?
| | Nervous System Malformations | 1 | 2014 | 34 | 0.120 |
Why?
| | Disease Management | 1 | 2018 | 560 | 0.110 |
Why?
| | Disease Progression | 1 | 2021 | 2384 | 0.110 |
Why?
| | Parents | 1 | 2022 | 1190 | 0.110 |
Why?
| | Prospective Studies | 3 | 2022 | 6216 | 0.110 |
Why?
| | Point Mutation | 1 | 2014 | 216 | 0.110 |
Why?
| | Proteins | 1 | 2019 | 912 | 0.110 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1393 | 0.100 |
Why?
| | Disease Models, Animal | 2 | 2019 | 3542 | 0.100 |
Why?
| | Age Factors | 1 | 2019 | 2889 | 0.100 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1314 | 0.100 |
Why?
| | Pediatrics | 1 | 2018 | 983 | 0.090 |
Why?
| | HEK293 Cells | 2 | 2019 | 593 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3031 | 0.060 |
Why?
| | Muscle Hypotonia | 1 | 2023 | 31 | 0.060 |
Why?
| | Failure to Thrive | 1 | 2023 | 32 | 0.060 |
Why?
| | Motor Skills | 1 | 2024 | 81 | 0.050 |
Why?
| | Suggestion | 1 | 2022 | 5 | 0.050 |
Why?
| | Munc18 Proteins | 1 | 2022 | 23 | 0.050 |
Why?
| | Chromosome Aberrations | 1 | 2022 | 138 | 0.050 |
Why?
| | Time-to-Treatment | 1 | 2023 | 147 | 0.050 |
Why?
| | Patient Acuity | 1 | 2021 | 42 | 0.050 |
Why?
| | Cerebral Palsy | 1 | 2022 | 80 | 0.050 |
Why?
| | Animals | 2 | 2019 | 31761 | 0.050 |
Why?
| | Data Interpretation, Statistical | 1 | 2022 | 322 | 0.040 |
Why?
| | Proteostasis Deficiencies | 1 | 2019 | 6 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 498 | 0.040 |
Why?
| | Unfolded Protein Response | 1 | 2019 | 43 | 0.040 |
Why?
| | Vitamin B 6 Deficiency | 1 | 2019 | 5 | 0.040 |
Why?
| | Vitamin B 6 | 1 | 2019 | 9 | 0.040 |
Why?
| | Pyridoxal Phosphate | 1 | 2019 | 20 | 0.040 |
Why?
| | Interviews as Topic | 1 | 2021 | 582 | 0.040 |
Why?
| | Interdisciplinary Communication | 1 | 2020 | 182 | 0.040 |
Why?
| | Pyridoxine | 1 | 2019 | 28 | 0.040 |
Why?
| | Diet, Ketogenic | 1 | 2019 | 33 | 0.040 |
Why?
| | White Matter | 1 | 2020 | 102 | 0.040 |
Why?
| | Corpus Callosum | 1 | 2019 | 56 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2020 | 295 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2020 | 440 | 0.040 |
Why?
| | Consensus | 1 | 2020 | 535 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 396 | 0.040 |
Why?
| | Autism Spectrum Disorder | 1 | 2022 | 323 | 0.040 |
Why?
| | Emotions | 1 | 2022 | 472 | 0.040 |
Why?
| | Down Syndrome | 1 | 2022 | 338 | 0.040 |
Why?
| | Alternative Splicing | 1 | 2019 | 188 | 0.040 |
Why?
| | Gastrointestinal Diseases | 1 | 2019 | 183 | 0.040 |
Why?
| | Advisory Committees | 1 | 2018 | 208 | 0.030 |
Why?
| | Alleles | 1 | 2019 | 791 | 0.030 |
Why?
| | Protein Conformation | 1 | 2019 | 811 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1773 | 0.030 |
Why?
| | Zebrafish | 1 | 2019 | 411 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1378 | 0.030 |
Why?
| | Organ Size | 1 | 2014 | 435 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2014 | 1690 | 0.020 |
Why?
| | Logistic Models | 1 | 2014 | 1843 | 0.020 |
Why?
| | Aged | 1 | 2022 | 19079 | 0.010 |
Why?
| | United States | 1 | 2020 | 12176 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 26746 | 0.010 |
Why?
|
|
Demarest's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|